Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Immunohistochemical detection of "ex novo" HLA-DR in tumor cells determines clinical outcome in laryngeal cancer patients.

HLA - 1 Dec 2021

Prampolini Chiara, Almadori Giovanni, Bonvissuto Davide, Barba Marta, Giraldi Luca, Boccia Stefania, Paludetti Gaetano, Galli Jacopo, Parolini Ornella, Settimi Stefano, Cadoni Gabriella

Abstract excerpt

There are controversial results about the role of "ex novo" HLA-DR expression by tumor cells and its correlation with the oncological outcomes. Unfortunately, little is known about HLA-DR expression in laryngeal cancer tumor cells. The main purpose of this retrospective study is to strengthen the usefulness of studying "ex novo" HLA-DR expression on tumor cells from primary laryngeal squamous cell carcinoma...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alleles
Share to Carcinoma, Squamous Cell

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to HLA-DR Antigens

Share to Laryngeal Neoplasms

Share to Neoplasm Recurrence, Local

Source

Identifiers

PMID: 34605215
DOI: 10.1111/tan.14441

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Immunohistochemical detection of "ex novo" HLA-DR in tumor cells determines clinical outcome in laryngeal cancer patients.PMID 34605215Read ↗

HLA traits linked to development of head and neck squamous cell carcinoma affect the progression-free survival of patients.Semantic proximity Read ↗

The Role of Non-classical and Chain-Related Human Leukocyte Antigen Polymorphisms in Laryngeal Squamous Cell CarcinomaSemantic proximity Read ↗

High expression of HLA-DQA1 predicts poor outcome in patients with esophageal squamous cell carcinoma in Northern ChinaSemantic proximity Read ↗

The transition from HLA-I positive to HLA-I negative primary tumors: the road to escape from T-cell responses.Semantic proximity Read ↗

High frequency of altered HLA class I phenotypes in laryngeal carcinomas.Semantic proximity Read ↗

The HLA crossroad in tumor immunology.Semantic proximity Read ↗

Germline HLA-I genotypes predict pathologic response and survival outcomes in esophageal cancer patients undergoing neoadjuvant immunochemotherapy: a retrospective cohort study.Semantic proximity Read ↗

Tumor HLA‐DR expression linked to early intrahepatic recurrence of hepatocellular carcinomaSemantic proximity Read ↗

Outcome differences in HPV-driven head and neck squamous cell carcinoma attributable to altered human leukocyte antigen frequenciesSemantic proximity Read ↗

Loss of HLA-DR expression is related to tumor microenvironment and predicts adverse outcome in diffuse large B-cell lymphoma.Semantic proximity Read ↗

Human monoclonal antibodies as a tool for the detection of HLA class I allele-specific expression loss in head-and-neck squamous cell carcinoma and corresponding lymph node metastases.Semantic proximity Read ↗

The role of non-classical and chain-related human leukocyte antigen polymorphisms in laryngeal squamous cell carcinoma.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.